Cargando…
Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats
BACKGROUND AND AIMS: The effect of red palm oil (RPO) supplementation on infarct size after ischaemia/reperfusion in a cholesterol enriched diet-induced hyperlipidemic animal model has not been reported. Previous studies reported results on the effect of RPO in a normal diet, whilst evidence of prot...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148975/ https://www.ncbi.nlm.nih.gov/pubmed/21689423 http://dx.doi.org/10.1186/1476-511X-10-103 |
_version_ | 1782209396713979904 |
---|---|
author | Szucs, Gergo Bester, Dirk J Kupai, Krisztina Csont, Tamas Csonka, Csaba Esterhuyse, Adriaan J Ferdinandy, Peter Van Rooyen, Jacques |
author_facet | Szucs, Gergo Bester, Dirk J Kupai, Krisztina Csont, Tamas Csonka, Csaba Esterhuyse, Adriaan J Ferdinandy, Peter Van Rooyen, Jacques |
author_sort | Szucs, Gergo |
collection | PubMed |
description | BACKGROUND AND AIMS: The effect of red palm oil (RPO) supplementation on infarct size after ischaemia/reperfusion in a cholesterol enriched diet-induced hyperlipidemic animal model has not been reported. Previous studies reported results on the effect of RPO in a normal diet, whilst evidence of protection has been linked to improved functional recovery, prosurvival kinase, anti-apoptosis and NO-cGMP. Therefore, we aimed to investigate the effects of dietary RPO supplementation in a cholesterol-enriched diet-induced hyperlipidemic rat model and to investigate the involvement of matrix metalloproteinase 2 (MMP2) inhibition as a possible mechanism of protection. MATERIALS AND METHODS: Male Wistar rats were fed either a standard rat chow diet (Norm) or a 2% cholesterol-enriched diet (Chol) for nine weeks. Additionally, two more groups received the same treatment, however, at the week 4, diet was supplemented with RPO for the last five weeks (Norm+RPO and Chol+RPO), respectively. After the feeding period hearts were isolated, perfused according to Langendorff and subjected to 30 minutes of normothermic global ischaemia followed by two hours of reperfusion. Infarct size was measured by 2,3,5-triphenyltetrazolium chloride staining at the end of reperfusion. RESULTS: Cholesterol-enriched diet increased myocardial infarct size from 23.5 ± 3.0% to 37.2 ± 3.6% (p < 0.05) when compared to normal diet. RPO supplementation significantly reduced infarct size either in Norm+RPO or in Chol+RPO (to 9.2 ± 1.0% and 26.9 ± 3.0%), respectively. Infarct size in Chol+RPO was comparable to the Norm group. MMP2 activity before ischaemia was significantly reduced in the Chol+RPO group when compared to the Chol group. However, the MMP2 activity of the hearts of the RPO fed rats was significantly increased when compared to the normal diet group after ischaemia. CONCLUSIONS: For the first time it was shown that dietary RPO supplementation attenuated the increased susceptibility of the hearts in cholesterol fed rats to ischaemia/reperfusion injury. This was shown by reduced infarct size. For the first time we also show that red palm oil supplementation altered pre-ischaemic levels of MMP-2, which may indicate that myocardial MMP2 may be implicated as a possible role player in RPO mediated protection against ischaemia/reperfusion injury in hearts of cholesterol supplemented rats. |
format | Online Article Text |
id | pubmed-3148975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31489752011-08-03 Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats Szucs, Gergo Bester, Dirk J Kupai, Krisztina Csont, Tamas Csonka, Csaba Esterhuyse, Adriaan J Ferdinandy, Peter Van Rooyen, Jacques Lipids Health Dis Research BACKGROUND AND AIMS: The effect of red palm oil (RPO) supplementation on infarct size after ischaemia/reperfusion in a cholesterol enriched diet-induced hyperlipidemic animal model has not been reported. Previous studies reported results on the effect of RPO in a normal diet, whilst evidence of protection has been linked to improved functional recovery, prosurvival kinase, anti-apoptosis and NO-cGMP. Therefore, we aimed to investigate the effects of dietary RPO supplementation in a cholesterol-enriched diet-induced hyperlipidemic rat model and to investigate the involvement of matrix metalloproteinase 2 (MMP2) inhibition as a possible mechanism of protection. MATERIALS AND METHODS: Male Wistar rats were fed either a standard rat chow diet (Norm) or a 2% cholesterol-enriched diet (Chol) for nine weeks. Additionally, two more groups received the same treatment, however, at the week 4, diet was supplemented with RPO for the last five weeks (Norm+RPO and Chol+RPO), respectively. After the feeding period hearts were isolated, perfused according to Langendorff and subjected to 30 minutes of normothermic global ischaemia followed by two hours of reperfusion. Infarct size was measured by 2,3,5-triphenyltetrazolium chloride staining at the end of reperfusion. RESULTS: Cholesterol-enriched diet increased myocardial infarct size from 23.5 ± 3.0% to 37.2 ± 3.6% (p < 0.05) when compared to normal diet. RPO supplementation significantly reduced infarct size either in Norm+RPO or in Chol+RPO (to 9.2 ± 1.0% and 26.9 ± 3.0%), respectively. Infarct size in Chol+RPO was comparable to the Norm group. MMP2 activity before ischaemia was significantly reduced in the Chol+RPO group when compared to the Chol group. However, the MMP2 activity of the hearts of the RPO fed rats was significantly increased when compared to the normal diet group after ischaemia. CONCLUSIONS: For the first time it was shown that dietary RPO supplementation attenuated the increased susceptibility of the hearts in cholesterol fed rats to ischaemia/reperfusion injury. This was shown by reduced infarct size. For the first time we also show that red palm oil supplementation altered pre-ischaemic levels of MMP-2, which may indicate that myocardial MMP2 may be implicated as a possible role player in RPO mediated protection against ischaemia/reperfusion injury in hearts of cholesterol supplemented rats. BioMed Central 2011-06-20 /pmc/articles/PMC3148975/ /pubmed/21689423 http://dx.doi.org/10.1186/1476-511X-10-103 Text en Copyright © 2011 Szucs et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Szucs, Gergo Bester, Dirk J Kupai, Krisztina Csont, Tamas Csonka, Csaba Esterhuyse, Adriaan J Ferdinandy, Peter Van Rooyen, Jacques Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats |
title | Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats |
title_full | Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats |
title_fullStr | Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats |
title_full_unstemmed | Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats |
title_short | Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats |
title_sort | dietary red palm oil supplementation decreases infarct size in cholesterol fed rats |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148975/ https://www.ncbi.nlm.nih.gov/pubmed/21689423 http://dx.doi.org/10.1186/1476-511X-10-103 |
work_keys_str_mv | AT szucsgergo dietaryredpalmoilsupplementationdecreasesinfarctsizeincholesterolfedrats AT besterdirkj dietaryredpalmoilsupplementationdecreasesinfarctsizeincholesterolfedrats AT kupaikrisztina dietaryredpalmoilsupplementationdecreasesinfarctsizeincholesterolfedrats AT csonttamas dietaryredpalmoilsupplementationdecreasesinfarctsizeincholesterolfedrats AT csonkacsaba dietaryredpalmoilsupplementationdecreasesinfarctsizeincholesterolfedrats AT esterhuyseadriaanj dietaryredpalmoilsupplementationdecreasesinfarctsizeincholesterolfedrats AT ferdinandypeter dietaryredpalmoilsupplementationdecreasesinfarctsizeincholesterolfedrats AT vanrooyenjacques dietaryredpalmoilsupplementationdecreasesinfarctsizeincholesterolfedrats |